CHINASA ANUGWOM: Open Payments
NPI 1770613507 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 17 payments from 12 companies in 2025. Trend: 2023 $489 · 2024 $496 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $122 |
| Lilly USA, LLC | 3 | $60 |
| Abbott Laboratories | 2 | $50 |
| PFIZER INC. | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
| Dexcom, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| TOLMAR, INC. | 1 | $17 |
| Indivior Inc. | 1 | $17 |
Products named: Symbravo, MOUNJARO, ZORYVE, FREESTYLE LIBRE 3, PAXLOVID, Dexcom G6 Transmitter, PROCLAIM, ZEPBOUND.
Industry payments across TX — which companies pay providers there.
